| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1042981954 |
| P356 | DOI | 10.2165/11532570-000000000-00000 |
| P698 | PubMed publication ID | 20481646 |
| P2093 | author name string | Victoria L Vetter | |
| Josephine Elia | |||
| P2860 | cites work | Attention-deficit hyperactivity disorder and thyroid function | Q54228911 |
| Electrocardiographic screening in children with attention-deficit hyperactivity disorder | Q54487761 | ||
| Clinical pharmacology of tomoxetine, a potential antidepressant. | Q55061178 | ||
| Single-Dose Pharmacokinetics of Methylphenidate in CYP2D6 Extensive and Poor Metabolizers | Q57258447 | ||
| Attenuated 24-h heart rate variability in apparently healthy subjects, subsequently suffering sudden cardiac death | Q57309212 | ||
| A Prospective Four-Year Follow-up Study of Children at Risk for ADHD: Psychiatric, Neuropsychological, and Psychosocial Outcome | Q57400590 | ||
| Anxiety and autonomic flexibility: a cardiovascular approach | Q61010176 | ||
| Two subgroups of hyperactives as adults: correlations of outcome | Q67977929 | ||
| The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study | Q68890283 | ||
| Ventricular dysrhythmias in children with Marfan's syndrome | Q70067303 | ||
| Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients | Q70676010 | ||
| Synthesis and pharmacology of hydroxylated metabolites of methyl phenidate | Q71068231 | ||
| Methylphenidate increases heart rate, blood pressure and plasma epinephrine in normal subjects | Q71365440 | ||
| Early after-depolarisations induced by noradrenaline may be initiated by calcium released from sarcoplasmic reticulum | Q71918764 | ||
| ADHD is associated with early initiation of cigarette smoking in children and adolescents | Q72990183 | ||
| A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD | Q73256558 | ||
| Major coronary artery anomalies in a pediatric population: incidence and clinical importance | Q73536419 | ||
| Prospective screening of 5,615 high school athletes for risk of sudden cardiac death | Q73729681 | ||
| Neurodevelopmental outcome and lifestyle assessment in school-aged and adolescent children with hypoplastic left heart syndrome | Q73735055 | ||
| Cost effectiveness analysis of screening of high school athletes for risk of sudden cardiac death | Q73745098 | ||
| Heart rate dynamics at the onset of ventricular tachyarrhythmias as retrieved from implantable cardioverter-defibrillators in patients with coronary artery disease | Q73815495 | ||
| Clinical significance of abnormal electrocardiographic patterns in trained athletes | Q74014418 | ||
| Screening for hypertrophic cardiomyopathy in young athletes | Q74837363 | ||
| Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and M | Q79923799 | ||
| Hyperactive children as young adults: driving abilities, safe driving behavior, and adverse driving outcomes | Q80139020 | ||
| Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder | Q81735356 | ||
| Usefulness and cost effectiveness of cardiovascular screening of young adolescents | Q82180645 | ||
| Young adult outcome of hyperactive children: adaptive functioning in major life activities | Q82335174 | ||
| The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers | Q50484408 | ||
| Abnormal ambulatory electrocardiographic findings in patients with the Marfan syndrome | Q50961959 | ||
| Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder | Q51017485 | ||
| Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles | Q51028358 | ||
| Heart period and QT variability, hostility, and type-A behavior in normal controls and patients with panic disorder | Q51070551 | ||
| Symptoms of anxiety and risk of coronary heart disease. The Normative Aging Study | Q51130104 | ||
| Biphasic Inotropic Effects of Methamphetamine and Methylphenidate on Ferret Papillary Muscles | Q51531686 | ||
| Cardiovascular effects of mixed amphetamine salts extended release in the treatment of school-aged children with attention-deficit/hyperactivity disorder | Q51935749 | ||
| Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence? | Q51991799 | ||
| Adult Psychiatric Status of Hyperactive Boys Grown Up | Q51995300 | ||
| Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status | Q52035084 | ||
| Increased QT variability in patients with panic disorder and depression | Q52080013 | ||
| Effect of CYP2D1 inhibition on the behavioural effects of d-amphetamine | Q52194085 | ||
| Marfan syndrome: neuropsychological aspects | Q52249970 | ||
| Subchronic fluoxetine treatment induces a transient potentiation of amphetamine-induced hyperlocomotion: possible pharmacokinetic interaction | Q52278558 | ||
| Efficacy of personal symptom and family history questionnaires when screening for inherited cardiac pathologies: the role of electrocardiography | Q53230422 | ||
| Increased prevalence of ADHD in Turner syndrome with no evidence of imprinting effects | Q53633338 | ||
| Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type | Q53678879 | ||
| The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis | Q22241865 | ||
| Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder | Q22242745 | ||
| Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis | Q24655643 | ||
| Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies | Q28036762 | ||
| Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes | Q28144206 | ||
| The worldwide prevalence of ADHD: a systematic review and metaregression analysis | Q28304626 | ||
| Atrioventricular nodal re-entrant tachycardia associated with stimulant treatment | Q28371746 | ||
| Fluoxetine-related death in a child with cytochrome P-450 2D6 genetic deficiency | Q28376123 | ||
| Social functioning and emotional regulation in the attention deficit hyperactivity disorder subtypes | Q30305385 | ||
| Effect of stimulant medication on driving performance of young adults with attention-deficit hyperactivity disorder: a preliminary double-blind placebo controlled trial | Q30305602 | ||
| Marfan's syndrome and the heart. | Q30482248 | ||
| Prenatal and perinatal striatal injury: a hypothetical cause of attention-deficit-hyperactivity disorder? | Q30582463 | ||
| Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome | Q33156201 | ||
| Case study: adverse response to clonidine | Q33175123 | ||
| Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors | Q33668203 | ||
| Apolipoprotein E genotype modifies the risk of behavior problems after infant cardiac surgery | Q33734244 | ||
| Heart rate variability in depressive and anxiety disorders | Q34048919 | ||
| Hypertrophic cardiomyopathy: a systematic review | Q34117625 | ||
| Sudden death in young athletes | Q34229613 | ||
| A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain | Q34246779 | ||
| Impact of executive function deficits and attention-deficit/hyperactivity disorder (ADHD) on academic outcomes in children | Q34358505 | ||
| Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program | Q34571316 | ||
| Attention deficit/hyperactivity disorder and methylphenidate. A review of height/weight, cardiovascular, and somatic complaint side effects | Q35000368 | ||
| Emotional and behavioral difficulties and impairments in everyday functioning among children with a history of attention-deficit/hyperactivity disorder. | Q35024455 | ||
| Cardiovascular effects of atomoxetine in children, adolescents, and adults | Q35178553 | ||
| Prevalence of ventricular preexcitation in Japanese schoolchildren | Q35367486 | ||
| Academic performance and behavioral difficulties after neonatal and infant heart surgery | Q35961365 | ||
| Amplification of spatial dispersion of repolarization underlies sudden cardiac death associated with catecholaminergic polymorphic VT, long QT, short QT and Brugada syndromes | Q36335253 | ||
| Phobic anxiety, depression, and risk of ventricular arrhythmias in patients with coronary heart disease | Q36608953 | ||
| An autonomic flexibility-neurovisceral integration model of anxiety and cardiac vagal tone | Q36636818 | ||
| ADHD characteristics: I. Concurrent co-morbidity patterns in children & adolescents | Q36817709 | ||
| Cardiac safety of methylphenidate versus amphetamine salts in the treatment of ADHD. | Q37376330 | ||
| Cardiac risk assessment before the use of stimulant medications in children and youth: A joint position statement by the Canadian Paediatric Society, the Canadian Cardiovascular Society, and the Canadian Academy of Child and Adolescent Psychiatry | Q37419415 | ||
| Role of the sympathetic nervous system in the genesis of ventricular arrhythmia | Q37593424 | ||
| A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study). | Q38450463 | ||
| Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder | Q38560293 | ||
| Driving-related risks and outcomes of attention deficit hyperactivity disorder in adolescents and young adults: a 3- to 5-year follow-up survey. | Q38566991 | ||
| Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial. | Q40466789 | ||
| ADHD comorbidity findings from the MTA study: comparing comorbid subgroups | Q40723668 | ||
| Atrial fibrillation in children | Q40831614 | ||
| The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment | Q40850649 | ||
| Comorbidity in ADHD: Implications for Research, Practice, and DSM-V | Q40886212 | ||
| Sudden death from cardiac causes in children and young adults | Q40968766 | ||
| The relationship of attention deficit hyperactivity disorder and conduct disorder to juvenile delinquency: legal implications | Q41186291 | ||
| Etiology and pathogenesis of attention-deficit hyperactivity disorder (ADHD): significance of prematurity and perinatal hypoxic-haemodynamic encephalopathy | Q41256701 | ||
| Medications for attention deficit hyperactivity disorder: cardiovascular concerns | Q41675021 | ||
| Late neurodevelopmental outcome after repair of total anomalous pulmonary venous connection | Q41920465 | ||
| Neonatal anoxia induces transitory hyperactivity, permanent spatial memory deficits and CA1 cell density reduction in developing rats. | Q42619581 | ||
| Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial. | Q42679957 | ||
| The metabolic fate of amphetamine in man and other species | Q42935084 | ||
| Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder | Q43456283 | ||
| Prevalence of abnormal electrocardiograms in a large, unselected population undergoing pre-participation cardiovascular screening. | Q43549749 | ||
| The Wolff-Parkinson-White syndrome associated with Marfan's syndrome | Q43612868 | ||
| Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Dose-Response Study | Q43789283 | ||
| Developmental Aspects of Psychostimulant Treatment in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder | Q43838822 | ||
| Stability over time of heart period variability in patients with previous myocardial infarction and ventricular arrhythmias. The CAPS and ESVEM investigators | Q43996358 | ||
| 24-hour ambulatory blood pressure monitoring in male children receiving stimulant therapy | Q44042907 | ||
| Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study. | Q44201499 | ||
| Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies | Q44290885 | ||
| Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma | Q44317525 | ||
| Methylphenidate treatment for attention-deficit/hyperactivity disorder in children and adolescents with velocardiofacial syndrome: an open-label study. | Q44682252 | ||
| Long-term outcome in patients with Marfan syndrome: is aortic dissection the only cause of sudden death? | Q44690318 | ||
| Effects of once-daily osmotic-release methylphenidate on blood pressure and heart rate in children with attention-deficit/hyperactivity disorder: results from a one-year follow-up study | Q44717857 | ||
| Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening. | Q44858865 | ||
| Sudden death and use of stimulant medications in youths. | Q45968311 | ||
| Preliminary evidence of the association between the history of childhood attention-deficit/hyperactivity disorder and smoking treatment failure. | Q45980457 | ||
| ?-Adrenergic increase in the calcium conductance of cardiac myocytes studied with the patch clamp | Q46172420 | ||
| Cardiac arrest with pulseless electrical activity associated with methylphenidate in an adolescent with a normal baseline echocardiogram | Q46289725 | ||
| Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants | Q46485452 | ||
| Short- and long-term cardiovascular effects of mixed amphetamine salts extended release in children | Q46719438 | ||
| Cardiac arrest during induction of anaesthesia in a child on long-term amphetamine therapy | Q46752641 | ||
| Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: a double-blind, randomized, cross-over trial. | Q46778584 | ||
| Long-term cardiovascular effects of mixed amphetamine salts extended release in adults with ADHD. | Q46848196 | ||
| Acute fluoxetine treatment potentiates amphetamine hyperactivity and amphetamine-induced nucleus accumbens dopamine release: possible pharmacokinetic interaction | Q48255830 | ||
| Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes | Q48357634 | ||
| Development of monoamine systems after neonatal anoxia in rats | Q48373486 | ||
| Decreased heart-period variability in patients with panic disorder: a study of Holter ECG records | Q48801460 | ||
| P433 | issue | 3 | |
| P921 | main subject | attention deficit hyperactivity disorder | Q181923 |
| attention | Q6501338 | ||
| P304 | page(s) | 165-175 | |
| P577 | publication date | 2010-06-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Pediatric Drugs | Q15767256 |
| P1476 | title | Cardiovascular effects of medications for the treatment of attention-deficit hyperactivity disorder: what is known and how should it influence prescribing in children? | |
| P478 | volume | 12 |
| Q39647161 | Adverse Events in Medication Treatment-Naïve Children with Attention-Deficit/Hyperactivity Disorder: Results from a Small, Controlled Trial of Lisdexamfetamine Dimesylate |
| Q35065977 | Attention-deficit/hyperactivity disorder and adverse health outcomes |
| Q37033964 | Attention-deficit/hyperactivity disorder in older adults: prevalence and possible connections to mild cognitive impairment |
| Q34461113 | Attention-deficit/hyperactivity disorder treatment: what are the long-term cardiovascular risks? |
| Q38240014 | Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder: an update |
| Q48265331 | Clinical Significance of Prolonged QTc Interval in Williams Syndrome |
| Q39834928 | Does Prior Exposure to Stimulants in Children with ADHD Impact Cardiovascular Parameters from Lisdexamfetamine Dimesylate? |
| Q41899976 | How to predict the impact of methylphenidate on cardiovascular risk in children with attention deficit disorder: methylphenidate improves autonomic dysfunction in children with ADHD. |
| Q34182040 | One-year prospective follow-up of pharmacological treatment in children with attention-deficit/hyperactivity disorder |
| Q38052186 | Pediatric cardiovascular safety: Challenges in drug and device development and clinical application |
| Q38014595 | Psychosocial treatments for ADHD: a systematic appraisal of the evidence. |
| Q38060572 | Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder. |
| Q33160890 | Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorder |
| Q35600580 | Transdermal and Oral dl-Methylphenidate–Ethanol Interactions in C57BL/6J Mice: Transesterification to Ethylphenidate and Elevation of d-Methylphenidate Concentrations |
Search more.